BridgeMD
New treatment option for Stroke
Official title Assessment of an Intensive Motor Telerehabilitation Program for Stroke Patients
ClinicalTrials.gov ID: NCT07254195
What this study is testing
- What it's testing
- Stroke is a major cause of motor disability, particularly hemiplegia, and its incidence is increasing as the population ages. Despite partial spontaneous recovery in the first three months, 80% of patients retain a motor deficit after six months, requiring intensive rehabilitation to maximize recovery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Hospitalized for a first ischemic or hemorrhagic stroke
- Stroke occurrence more than 30 days prior
- Presenting motor deficits affecting the upper limb, with or without involvement of the lower limb
- Able to follow the instructions of the home program using the MindMotion GO device
- Having at home an accessible email address, an Internet connection with password, a smartphone, a screen or TV with HDMI input (Full HD 1080p...
You likely can't join if
- History of stroke
- Neurological pathology other than stroke
- Patient with uncontrolled epilepsy or seizure disorder
- Cardiac disease limiting exercise
- Pain limiting rehabilitation dose
- Major comprehension problems or severe psychiatric and/or cognitive disorders that could compromise understanding of the protocol and the smooth...
See the full eligibility criteria
- Hospitalized for a first ischemic or hemorrhagic stroke
- Stroke occurrence more than 30 days prior
- Presenting motor deficits affecting the upper limb, with or without involvement of the lower limb
- Able to follow the instructions of the home program using the MindMotion GO device
- Having at home an accessible email address, an Internet connection with password, a smartphone, a screen or TV with HDMI input (Full HD 1080p resolution), and a free space of approximately 1 m x 2.5 m in front of the...
- Ability to sit without assistance
- Patient agreeing to participate in the study by signing an informed consent form
- Affiliated with, or entitled to, a social security scheme
- History of stroke
- Neurological pathology other than stroke
- Patient with uncontrolled epilepsy or seizure disorder
- Cardiac disease limiting exercise
- Pain limiting rehabilitation dose
- Major comprehension problems or severe psychiatric and/or cognitive disorders that could compromise understanding of the protocol and the smooth running of the study.
- Uncorrected hearing or visual deficits
- Severe apraxia
- Severe memory impairment
- Severe unilateral spatial neglect
- Total plegia of affected limb
- Pregnant, parturient or breast-feeding women
- Persons deprived of their liberty by judicial or administrative decision
- Persons admitted to a health or social institution for purposes other than research
- Adults under legal protection (guardianship, curatorship)
- people participating in other intervention research.
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Genis-Laval, Lyon, France
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Genis-Laval, Lyon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.